SPS
BEAM icon

Susquehanna Portfolio Strategies’s Beam Therapeutics BEAM Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29M Hold
138,132
– – 0.05% 388
2025
Q4 		$3.83M Hold
138,132
– – 0.06% 354
2025
Q3 		$3.35M Buy
138,132
+14,641
+12% +$291K 0.05% 388
2025
Q2 		$2.1M Buy
+123,491
New +$2.15M 0.05% 364
2024
Q4 		– Sell
-126,710
Closed -$3.1M – 53
2024
Q3 		$3.1M Sell
126,710
-17,844
-12% -$461K 0.21% 105
2024
Q2 		$3.39M Hold
144,554
– – 0.14% 155
2024
Q1 		$4.78M Hold
144,554
– – 0.11% 221
2023
Q4 		$3.93M Buy
+144,554
New +$3.59M 0.07% 319

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Susquehanna Portfolio Strategies's BEAM Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 138,132 shares worth $3.29M. The position accounts for 0.05% of the portfolio, ranked #388.

Susquehanna Portfolio Strategies first reported a position in BEAM in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.78M in Q1 2024. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Susquehanna Portfolio Strategies held 138,132 shares of Beam Therapeutics worth $3.29M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up 0.05% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #388 holding.
  • Susquehanna Portfolio Strategies first reported a position in Beam Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • Susquehanna Portfolio Strategies's Beam Therapeutics position peaked at $4.78M in Q1 2024.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.